A Multicenter, Prospective, Randomized Controlled Clinical Trial Assessing the Efficacy of a Novel Cellular, Acellular, Matrix-like Product (CAMP) Plus Standard of Care Versus Standard of Care Alone in the Management of Post-Mohs Micrographic Surgery Defects.

Clinical trial NCT07695389 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07695389
Sponsor: BioLab Holdings
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Undergone Mohs Micrographic Surgery Cutaneous Malignancy Mohs Surgical Defect

Start date: 2026-07-01
Primary completion: 2028-07-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.